{
  "npi": "1396283628",
  "enumeration_type": "NPI-2",
  "basic": {
    "authorized_official_first_name": "MELISSA",
    "authorized_official_last_name": "COCHRAN",
    "authorized_official_name_prefix": "--",
    "authorized_official_name_suffix": "--",
    "authorized_official_telephone_number": "9047372722",
    "authorized_official_title_or_position": "Credentialing Coordinator",
    "certification_date": "2020-12-23",
    "enumeration_date": "2017-02-07",
    "last_updated": "2020-12-23",
    "organization_name": "A ABDALLA, INC",
    "organizational_subpart": "NO",
    "status": "A"
  },
  "taxonomies": [
    {
      "code": "207RN0300X",
      "desc": "Internal Medicine, Nephrology",
      "license": "ME128260",
      "primary": true,
      "state": "FL",
      "taxonomy_group": "193400000X - Single Specialty Group"
    }
  ],
  "enrichment": {
    "plain_english_specialty": "Board-Certified Nephrologist (Kidney Function, Stones & Dialysis Specialist)",
    "certifying_board": "American Board of Internal Medicine — Nephrology",
    "common_medicare_procedures": [
      "Chronic Kidney Disease (eGFR & Albuminuria) Staging & Renoprotective Planning",
      "24-Hour Urine Metabolic Evaluation for Recurrent Kidney Stones",
      " Outpatient Hemodialysis & Peritoneal Dialysis Oversight (CPT 90960)",
      "Renal Biopsy Evaluation & Secondary Hypertension Workup"
    ],
    "common_part_d_therapeutic_classes": [
      "SGLT2 Inhibitors (Dapagliflozin, Empagliflozin) & Finerenone for CKD",
      "ACE Inhibitors / ARBs for Proteinuria Reduction",
      "Potassium Citrate & Thiazide Diuretics (Kidney Stone Prevention)",
      "Erythropoiesis-Stimulating Agents & Phosphate Binders"
    ]
  }
}